177 related articles for article (PubMed ID: 38778769)
1. Three-dimensional cardiac models: a pre-clinical testing platform.
Groen E; Mummery CL; Yiangou L; Davis RP
Biochem Soc Trans; 2024 Jun; 52(3):1045-1059. PubMed ID: 38778769
[TBL] [Abstract][Full Text] [Related]
2. Generating 3D human cardiac constructs from pluripotent stem cells.
Liu C; Feng X; Li G; Gokulnath P; Xiao J
EBioMedicine; 2022 Feb; 76():103813. PubMed ID: 35093634
[TBL] [Abstract][Full Text] [Related]
3. From engineered heart tissue to cardiac organoid.
Cho J; Lee H; Rah W; Chang HJ; Yoon YS
Theranostics; 2022; 12(6):2758-2772. PubMed ID: 35401829
[TBL] [Abstract][Full Text] [Related]
4. From Spheroids to Organoids: The Next Generation of Model Systems of Human Cardiac Regeneration in a Dish.
Scalise M; Marino F; Salerno L; Cianflone E; Molinaro C; Salerno N; De Angelis A; Viglietto G; Urbanek K; Torella D
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947977
[TBL] [Abstract][Full Text] [Related]
5. Robust generation of human-chambered cardiac organoids from pluripotent stem cells for improved modelling of cardiovascular diseases.
Ho BX; Pang JKS; Chen Y; Loh YH; An O; Yang HH; Seshachalam VP; Koh JLY; Chan WK; Ng SY; Soh BS
Stem Cell Res Ther; 2022 Dec; 13(1):529. PubMed ID: 36544188
[TBL] [Abstract][Full Text] [Related]
6. Engineered platforms for mimicking cardiac development and drug screening.
Stiefbold M; Zhang H; Wan LQ
Cell Mol Life Sci; 2024 Apr; 81(1):197. PubMed ID: 38664263
[TBL] [Abstract][Full Text] [Related]
7. Application of human pluripotent stem cells and pluripotent stem cell-derived cellular models for assessing drug toxicity.
Apáti Á; Varga N; Berecz T; Erdei Z; Homolya L; Sarkadi B
Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):61-75. PubMed ID: 30526128
[No Abstract] [Full Text] [Related]
8. Correlation between frataxin expression and contractility revealed by in vitro Friedreich's ataxia cardiac tissue models engineered from human pluripotent stem cells.
Wong AO; Wong G; Shen M; Chow MZ; Tse WW; Gurung B; Mak SY; Lieu DK; Costa KD; Chan CW; Martelli A; Nabhan JF; Li RA
Stem Cell Res Ther; 2019 Jul; 10(1):203. PubMed ID: 31286988
[TBL] [Abstract][Full Text] [Related]
9. The Use of Stem Cell-Derived Organoids in Disease Modeling: An Update.
Azar J; Bahmad HF; Daher D; Moubarak MM; Hadadeh O; Monzer A; Al Bitar S; Jamal M; Al-Sayegh M; Abou-Kheir W
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299287
[TBL] [Abstract][Full Text] [Related]
10. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
[TBL] [Abstract][Full Text] [Related]
11. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
[TBL] [Abstract][Full Text] [Related]
12. Oxygen Is an Ambivalent Factor for the Differentiation of Human Pluripotent Stem Cells in Cardiac 2D Monolayer and 3D Cardiac Spheroids.
Souidi M; Sleiman Y; Acimovic I; Pribyl J; Charrabi A; Baecker V; Scheuermann V; Pesl M; Jelinkova S; Skladal P; Dvorak P; Lacampagne A; Rotrekl V; Meli AC
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33440843
[TBL] [Abstract][Full Text] [Related]
13. Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells.
Li RA; Keung W; Cashman TJ; Backeris PC; Johnson BV; Bardot ES; Wong AOT; Chan PKW; Chan CWY; Costa KD
Biomaterials; 2018 May; 163():116-127. PubMed ID: 29459321
[TBL] [Abstract][Full Text] [Related]
14. Human pluripotent stem cell-based cardiovascular disease modeling and drug discovery.
Liu G; Liu Z; Cao N
Pflugers Arch; 2021 Jul; 473(7):1087-1097. PubMed ID: 33686477
[TBL] [Abstract][Full Text] [Related]
15. Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research.
Andrysiak K; Stępniewski J; Dulak J
Pflugers Arch; 2021 Jul; 473(7):1061-1085. PubMed ID: 33629131
[TBL] [Abstract][Full Text] [Related]
16. Cellular and Engineered Organoids for Cardiovascular Models.
Thomas D; Choi S; Alamana C; Parker KK; Wu JC
Circ Res; 2022 Jun; 130(12):1780-1802. PubMed ID: 35679369
[TBL] [Abstract][Full Text] [Related]
17. Maturing differentiated human pluripotent stem cells in vitro: methods and challenges.
Ottaviani D; Ter Huurne M; Elliott DA; Bellin M; Mummery CL
Development; 2023 Jun; 150(11):. PubMed ID: 37260361
[TBL] [Abstract][Full Text] [Related]
18. Human pluripotent-stem-cell-derived organoids for drug discovery and evaluation.
Vandana JJ; Manrique C; Lacko LA; Chen S
Cell Stem Cell; 2023 May; 30(5):571-591. PubMed ID: 37146581
[TBL] [Abstract][Full Text] [Related]
19. Deciphering Congenital Heart Disease Using Human Induced Pluripotent Stem Cells.
Zhang H; Wu JC
Adv Exp Med Biol; 2024; 1441():239-252. PubMed ID: 38884715
[TBL] [Abstract][Full Text] [Related]
20. In Situ Expansion, Differentiation, and Electromechanical Coupling of Human Cardiac Muscle in a 3D Bioprinted, Chambered Organoid.
Kupfer ME; Lin WH; Ravikumar V; Qiu K; Wang L; Gao L; Bhuiyan DB; Lenz M; Ai J; Mahutga RR; Townsend D; Zhang J; McAlpine MC; Tolkacheva EG; Ogle BM
Circ Res; 2020 Jul; 127(2):207-224. PubMed ID: 32228120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
